News
A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...
A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...
A groundbreaking clinical trial replaces surgery with immunotherapy for cancer patients. The results could change cancer treatment, offering new hope for those with specific genetic mutations.
A new study suggests that childhood exposure to a bacterial toxin could be driving the increase in colorectal cancer cases ...
Malnutrition in children with cancer has been identified as a part of the symptom complex of progressing and aggressive ...
Williams, 70, has to pay nearly $180,000 for his cancer therapy, of which more than $25,000 will go on GST. “It’s a tax on ...
Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Thank you for standing by. Hello and welcome to the Summit Therapeutics Q1 2025 Earnings Conference Call. I would now like to turn the call over ...
11hon MSN
A trailblazing breast cancer researcher at the University of Washington has not received $1.8 million in promised funding ...
With AI, Google DeepMind’s AlphaFold has been able to unfold the difficult mystery around the protein-folding problem that ...
Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show ...
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results